"Vasodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to cause dilation of the blood vessels.
| Descriptor ID |
D014665
|
| MeSH Number(s) |
D27.505.954.411.918
|
| Concept/Terms |
Vasodilator Agents- Vasodilator Agents
- Agents, Vasodilator
- Vasodilators
- Vasorelaxants
- Vasodilator Drugs
- Drugs, Vasodilator
|
Below are MeSH descriptors whose meaning is more general than "Vasodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Vasodilator Agents".
This graph shows the total number of publications written about "Vasodilator Agents" by people in this website by year, and whether "Vasodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 3 | 5 |
| 2004 | 1 | 1 | 2 |
| 2006 | 3 | 2 | 5 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 2 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 3 | 4 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 2 | 4 |
| 2017 | 27 | 20 | 47 |
| 2018 | 21 | 29 | 50 |
| 2019 | 5 | 7 | 12 |
| 2020 | 2 | 7 | 9 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Vasodilator Agents" by people in Profiles.
-
Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome. Crit Care. 2021 07 21; 25(1):258.
-
Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19. Br J Anaesth. 2021 09; 127(3):e111-e113.
-
Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients. PLoS One. 2021; 16(5):e0251048.
-
COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin. J Stroke Cerebrovasc Dis. 2021 Jul; 30(7):105822.
-
Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione. Am J Cardiovasc Drugs. 2021 Nov; 21(6):589-593.
-
Nicorandil a magic bullet or a double edged sword in critically ill COVID-19 patients? Clin Exp Pharmacol Physiol. 2021 06; 48(6):938-939.
-
Secondary Metabolites of Plants as Modulators of Endothelium Functions. Int J Mol Sci. 2021 Mar 03; 22(5).
-
Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report. A A Pract. 2021 Feb 05; 15(2):e01376.
-
Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 18; 22(1):60.
-
Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19. J Intensive Care Med. 2021 Mar; 36(3):327-333.